News

Johnson & Johnson Halts COVID-19 Trials

Written by Yourway | October 19, 2020

Johnson & Johnson has paused the advanced clinical trial of its experimental coronavirus vaccine due to an unexplained illness in one of the volunteers. "Following our guidelines, the participant's illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians," the company said in a statement regarding the study. At Yourway, we help mitigate risk in trials by giving clients the ability to seamlessly manage their inventory through an easy-to-use client portal.